2-[4-(4,5-Dihydro-1H-pyrrol-2-yl)phenyl]-4,5-dihydro-1H-imidazole

被引：7

作者：

Kia, Reza ^{[1
]}

Fun, Hoong-Kun ^{[1
]}

Kargar, Hadi ^{[2
]}

机构：

[1] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia

[2] PNU, Sch Sci, Dept Chem, Ardakan, Yazd, Iran

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2008年 / 64卷

关键词：

D O I：

10.1107/S160053680803818X

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

The molecule of the title compound, C12H14N4, lies about a crystallographic inversion centre. The five- and six-membered rings are twisted from each other, forming a dihedral angle of 18.06 (7)degrees. In the crystal structure, neighbouring molecules are linked by intermolecular N-H center dot center dot center dot N hydrogen bonds into one-dimensional infinite chains forming 18-membered rings with R-2(2)(18) motifs. The crystal structure is further stabilized by weak intermolecular pi-pi stacking [centroid-centroid distance = 3.8254 (6) angstrom] and C-H center dot center dot center dot pi interactions.

引用

页码：O2406 / U2996

页数：8

共 50 条

[31] Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice
Villarinho, Jardel Gomes
Fachinetto, Roselei
Pinheiro, Francielle de Vargas
Sant'Anna, Gabriela da Silva
Machado, Pablo
Dombrowski, Patricia Andreia
da Cunha, Claudio
Cabrini, Daniela de Almeida
Pinto Martins, Marcos Antonio
Bonacorso, Helio Gauze
Zanatta, Nilo
Rubin, Maribel Antonello
Ferreira, Juliano
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (01): : 31 - 39
[32] Crystal structure of 4,4-dimethyl-2-(trifluoromethyl)-4,5-dihydro-1H-imidazole, C6H9F3N2
Said, A. Musa
Warad, Ismail
Alzahrani, O. Seraj
Zarrouk, Abdelkader
Lentz, Dieter
[J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2019, 234 (03): : 579 - 580
[33] (S,Sp)-2-[4-(1-methylethyl)-4,5-dihydro-oxazol-1-yl]ferrocenecarboxylic acid
Stepnicka, P
Císarová, I
[J]. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2004, 60 : M288 - M290
[34] 2-[3-(4-Bromophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]4- phenyl-1,3-thiazole
Abdel-Wahab, Bakr F.
Mohamed, Hanan A.
Ng, Seik Weng
Tiekink, Edward R. T.
[J]. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O735 - +
[35] ULTRASOUND AND MICROWAVE ASSISTED SYNTHESIS OF 2-(5(4-(4-ARYL)-1-PHENYL-1H-PYRAZOL-3-YL)-4,5-DIHYDRO-1-PHENYL-1H-PYRAZOLE-3-YL)-4-SUBSTITUTED PHENOLS AND THEIR BIOLOGICAL ACTIVITY
Shivaraj
Sarasija, M.
Ashok, D.
[J]. INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2008, 18 (02) : 105 - 108
[36] 2-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-2,3-DIHYDRO-1H-INDOLES - NOVEL ALPHA-2-ADRENERGIC AGONISTS AND ANTAGONISTS
HLASTA, DJ
HAUBRICH, DR
LUTTINGER, DA
PERRONE, MH
SILBERNAGEL, MJ
WARD, SJ
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 17 - MEDI
[37] α2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole
Gentili, F
Bousquet, P
Brasili, L
Caretto, M
Carrieri, A
Dontenwill, M
Giannella, M
Marucci, G
Perfumi, M
Piergentili, A
Quaglia, W
Rascente, C
Pigini, M
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (01) : 32 - 40
[38] 1-[4-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINOPHENYL]-3-(SUBSTITUTED PHENYL)-2-PROPENE-1-ONE AS ANTIPARKINSONIAN AGENTS
SRIVASTAVA, VK
SINGH, S
PALIT, G
SHANKER, K
[J]. PHARMAZIE, 1986, 41 (08): : 598 - 599
[39] Reactions of metallated 1-hydroxy-2,2,4,5,5-pentamethyl-2,5-dihydro-1H-imidazole with functionalized nitroxyl radicals derived from 2,5-dihydro-1H-imidazole and 2,5-dihydro-1H-imidazole 3-oxide
V. A. Reznikov
[J]. Russian Chemical Bulletin, 2001, 50 : 665 - 668
[40] Recyclization of isopropyl 2-(1-aryl-4,5-dioxo-2-phenyl-4,5-dihydro-1H-pyrrol-3-yl)-2-oxoacetates by the action of thiourea
Dmitriev, M. V.
Silaichev, P. S.
Slepukhin, P. A.
Maslivets, A. N.
[J]. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2011, 47 (04) : 627 - 629

← 1 2 3 4 5 →